NextPlat (NXPL) Q2 2026 earnings summary

Executive summary

• Achieved significant sequential growth in e-commerce and contracted healthcare services, driving consolidated gross margin to a record 40% and nearly eliminating net loss.

• Net loss reduced by 87% year-over-year to $144,000, with adjusted profitability excluding a one-time $0.5 million professional fee expense.

• Operates in two segments: e-Commerce (satellite communications) and Healthcare (pharmacy, analytics, 340B program).

• Strategic acquisition near Pensacola and launch of a new healthcare e-commerce website are expected to further expand market reach and revenue streams.

• Turnaround efforts and operational efficiencies focused on higher-margin 340B and government healthcare contracts.

Financial highlights

• Q2 2026 net revenues were $11.9 million, up 21% sequentially but down 10% year-over-year due to industry reimbursement pressures.

• Consolidated gross profit rose 63% year-over-year to $4.7 million, with gross margin expanding to 40% from 22% in Q2 2025.

• Operating loss reduced by 93% to $127,000 from $1.8 million in Q2 2025; net loss was $144,000 or $0.05 per share, compared to $1.8 million or $0.69 per share a year ago.

• Ended the quarter with $11.9 million in cash and $14.2 million in working capital.

• Operating expenses were $4.8 million, up slightly due to a one-time professional fee; excluding this, expenses declined 8%.

Outlook and guidance

• Expects continued sequential and year-over-year revenue growth in healthcare, driven by new contracts and the Pensacola acquisition.

• Anticipates reaching and sustaining bottom-line profitability beginning in Q3 2026, barring transaction and integration costs.

• Priorities include expanding contract-based healthcare, sustaining gross margins, disciplined expense management, and evaluating strategic acquisitions.

• Management expects current liquidity and operational plans to support at least 12 months of operations.

• Launch of a nationwide medication fulfillment website in Q3 2026 is anticipated to expand reach and support future growth.